Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)

RAJAF Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.02	0.01	0.1	0
Cash & Short-Term Investments	0.02	0.01	0.1	0
Cash Growth	130.51%	-93.35%	33806.12%	-
Accounts Receivable	-	-	0.36	-
Other Receivables	0.12	0.01	0.02	0
Receivables	0.12	0.01	0.37	0
Inventory	-	-	0.48	0.69
Other Current Assets	0.2	0.49	0.18	0.26
Total Current Assets	0.33	0.5	1.13	0.95
Property, Plant & Equipment	3.05	0.25	1.99	1.73
Long-Term Deferred Tax Assets	0.04	-	-	-
Other Long-Term Assets	-	1.35	-	-
Total Assets	3.42	2.1	3.26	2.83
Accounts Payable	2.81	-	1.23	1.09
Accrued Expenses	-	-	0.06	0.03
Short-Term Debt	0.01	-	1.56	1.29
Current Portion of Leases	0.11	0.06	0.07	0
Current Income Taxes Payable	-	-	0	0
Other Current Liabilities	-	2.46	0.01	-
Total Current Liabilities	2.93	2.52	2.92	2.41
Long-Term Debt	0.43	0.41	0.41	0.41
Long-Term Leases	0.14	0.12	0.2	0.01
Total Liabilities	3.5	3.06	3.54	2.84
Common Stock	0.01	0.01	0.01	0.01
Additional Paid-In Capital	0.22	0.22	-	-
Retained Earnings	-0.4	-1.22	-0.5	-0.01
Comprehensive Income & Other	0.09	0.04	0.22	-0.01
Shareholders' Equity	-0.08	-0.95	-0.28	-0.01
Total Liabilities & Equity	3.42	2.1	3.26	2.83
Total Debt	0.69	0.59	2.24	1.72
Net Cash (Debt)	-0.68	-0.59	-2.14	-1.72
Net Cash Per Share	-0.01	-0.01	-0.02	-0.02
Filing Date Shares Outstanding	111.12	111.12	111.12	111.12
Total Common Shares Outstanding	111.12	111.12	100	100
Working Capital	-2.6	-2.02	-1.79	-1.46
Book Value Per Share	-0.00	-0.01	-0.00	-0.00
Tangible Book Value	-0.08	-0.95	-0.28	-0.01
Tangible Book Value Per Share	-0.00	-0.01	-0.00	-0.00
Buildings	-	-	0.69	0.67
Machinery	0.16	0.1	1.21	1.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.